Gene: SLC22A9
Official Full Name: solute carrier family 22 member 9provided by HGNC
Gene Summary: Enables short-chain fatty acid transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Involved in hormone transport; short-chain fatty acid transmembrane transport; and sodium-independent organic anion transport. Located in basolateral plasma membrane. Implicated in Lynch syndrome and mismatch repair cancer syndrome. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA05667 | SLC22A9 Knockout cell line (AC16) | Human | SLC22A9 | 1:3-1:4 | negative | Online Inquiry |
| KOA21111 | SLC22A9 Knockout cell line (BEAS-2B) | Human | SLC22A9 | 1:3~1:4 | negative | Online Inquiry |
| KOA36556 | SLC22A9 Knockout cell line (U-2932) | Human | SLC22A9 | 1:2-1:4 | negative | Online Inquiry |
| KOA51965 | SLC22A9 Knockout cell line (TPC-1) | Human | SLC22A9 | 1:5-1:8 | negative | Online Inquiry |
| KOA67367 | SLC22A9 Knockout cell line (NCM460) | Human | SLC22A9 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.